A strong yielding, multi-applications, late stage product pipeline

SKR-1

Skin Rejuvenation
$5B

AC-1

Acne Vulgaris
$3B

WH-1

Chronic Wounds
$3B

Other Programs

Scarring, Burns, Orphan Indications, Periodontitis and other
<$10B